NCT06483425Active, not recruiting
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 3 Jul 2024
Brief summary (registry, in English)
This clinical trial aims to investigate the role of biomarkers in guiding precision treatment for ovarian cancer. The study will explore the effectiveness of personalized treatment strategies based on specific biomarkers identified in ovarian cancer patients. By analyzing the correlation between biomarker profiles and treatment outcomes, the trial seeks to optimize treatment decisions and improve overall survival rates in ovarian cancer patients.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 24 Jun 2024
- Start date
- 1 Mar 2024
- Primary completion date
- 1 Dec 2028
- Lead sponsor
- Tongji Hospital
- Diseases
- Ovarian cancer
- NCT number
- NCT06483425
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Mar 2024 to the primary completion date, 1 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous participation in a conflicting clinical trial.
Other
- Inability to comply with study requirements or follow-up visits.
Who the study is looking for
- Patients diagnosed with ovarian cancer.
- Willingness to undergo biomarker testing.
- Ability to provide informed consent for participation in the study.
Age in the registry: 18 years to 80 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.